ONCOLife Issues
Featured Articles
Trending Articles
Improving Everolimus Safety in Oncology: Missed Opportunities in Risk Minimization
ONCOLife | 27 May 2025
START and OneOncology Partnership Expands Clinical Trials from Academia to Community
Clinical Trials | 27 May 2025
DNA-Based Immunotherapy IMNN-001 Shows Survival Gains in Advanced Ovarian Cancer
Clinical Trials | 23 May 2025
How the Integration of START and CURC Is Advancing Cancer Research and Clinical Trials
ONCOLife | 22 May 2025
FDA Approves First Blood Test for Alzheimer’s, Marking a Historic Shift in Early Detection
Neurology | 16 May 2025
START Doses First Patient in Trial of mRNA-4106, a Pan-Tumor Therapy for Solid Tumors
Clinical Trials | 15 May 2025
FDA Approves Emrelis as the First Targeted ADC for High c-Met Expressing Lung Cancer
FDA & EMA | 15 May 2025
EpCAM-Targeting ADC CX-2051 Shows Promising Efficacy in Advanced Colorectal Cancer
Clinical Trials
13 May 2025
Bria-IMT’s Early Promise: Biomarkers Signal Path to Personalized Therapy in Breast Cancer
Clinical Trials
2 May 2025
Leucid Bio Doses First Patient in Trial of LEU011, a CAR-T Therapy for Solid Tumors
Clinical Trials
12 May 2025
Zongertinib Demonstrates 71% Response Rate in HER2-Mutant Lung Cancer Treatment
Clinical Trials
2 May 2025
First-Ever KRAS G12D Inhibitor Zoldonrasib Shows 61% Response Rate in Lung Cancer
Clinical Trials
30 April 2025
Oncologists Struggle with Innovation Overload: 'The Growing Chasm in Cancer Care'
ONCOLife
10 May 2025
New AI-Powered Urine Test Detects Prostate Cancer with Higher Precision than PSA
ONCOLife
2 May 2025
First AI-Driven Diagnostic Tool Wins FDA Breakthrough Designation for Lung Cancer
FDA & EMA
30 April 2025